Get startedLog in
    Picture of Consun Pharmaceutical logo

    1681 — Consun Pharmaceutical Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Consun Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line5846967468641,020
    Depreciation
    Amortisation
    Non-Cash Items19.7-6.42-40-37.8-53.3
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital192-36.9165-84.556.7
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities8677269488191,087
    Capital Expenditures-53.7-98.3-51.6-52.6-109
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items28-200-317-179-77.9
    Sale of Fixed Assets
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-25.7-298-369-232-187
    Financing Cash Flow Items-21.4-12.9-10.9-27.568.9
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-280-167-342-280-729
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash557256254298159